Neutrophilic disease of the skin and intestines after ipilimumab treatment for malignant melanoma - simultaneous occurrence of pyoderma gangrenosum and colitis.
Department of Dermatology.
Berenice M
BM
Rudolph
1st Department of Medicine.
Frank
F
Staib
Department of Dermatology.
Esther
E
Von Stebut
Institute of Pathology, University Hospital Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
Michael
M
Hainz
Department of Dermatology.
Stephan
S
Grabbe
Department of Dermatology.
Carmen
C
Loquai
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003092:Colitis / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D020556:Neutrophil Infiltration; D017511:Pyoderma Gangrenosum / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D000074324:Ipilimumab